Gerresheimer Ag · XETR:GXI
Gerresheimer — Investor Day (December 2020)
37 slides from Gerresheimer's investor day presentation, Dec 8, 2020
Slide 1: Focus – Transform – Grow: Our Strategy for Sustainable, Profitable Growth
Focus – Transform – Grow: Our Strategy for Sustainable, Profitable Growth Dietmar Siemssen, CEO December 08, 2020
Slide 2: Transforming our Gerresheimer into a growth value as innovation leader
Transforming our Gerresheimer into a growth value as innovation leader and solution provider 12/08/2020 Capital Market Day
Slide 3: Slide 3
Slide 4: New Corporate Design
New Corporate Design 4 The Transformation Becomes Visual 12/08/2020 Capital Market Day
Slide 5: New Corporate Design
New Corporate Design 5 The Transformation Becomes Visual 12/08/2020 Capital Market Day
Slide 6: New Corporate Design: The Transformation Becomes Visual
New Corporate Design 6 The Transformation Becomes Visual Pathbreaking and driven Colors full of contrast and brightness in a dynamic combination are showing our willingness to innovate and to perform. 12/08/2020 Capital Market Day
Slide 7: New Corporate Design: The Transformation Becomes Visual
New Corporate Design 7 The Transformation Becomes Visual Pathbreaking and driven Colors full of contrast and brightness in a dynamic combination are showing our willingness to innovate and to perform. 12/08/2020 Capital Market Day
Slide 8: Agenda
Agenda 1. Strategy formula G: Becoming Innovation Leader and Solution Provider 2. Strategic Levers to Accelerate Growth – Growth – Innovation – Excellence – Leadership – Sustainability 3. Growth Outlook 12/08/2020 Capital Market Day
Slide 9: The World is Changing
The World is Changing 9 We Anticipate Global Mega Trends and Catch the Waves Emerging Increase in Urban population Markets: chronic diseases and growing upper Increasing health and aging classes care access population More self- Increasing medication and Focus on importance of individual Sustainabil
Slide 10: The Transformation is Ongoing
Mission: Leave Historical Stagnation Behind 10 formula G as Vehicle into Sustainable, Profitable Growth CAGR + 2% 2019 2015 The Transformation is Ongoing
Slide 11: Strong Vision: Developed for 2028
Strong Vision: Developed for 2028 11 Ambitious Goals in Five Strategic Directions Defined Vision 2028: Leading in Health and Well-Being Delivery Solutions 2019 12/08/2020 Capital Market Day
Slide 12: Execution: The Change and Growth Engine is Running
Execution: The Change and Growth Engine is Running 12 The Whole Organization Contributes Vision 2028: 2020 Leading in Health and Well-Being IT Gl Glass D Digitalization Delivery Solutions F I Innovation HR Sus Sustain- ability Investor IR Relation Mergers & M&A Acquisitions Implement Numerous Strate
Slide 13: The Transformation is Ongoing: Set Ambitious Targets
Set Ambitious Targets and Achieve Them 13 Growth Acceleration in the Mid-Term …to high single CAGR from mid single… CAGR + 2% 2022 2019 2015 The Transformation is Ongoing
Slide 14: Agenda
Agenda 1. Strategy formula G: Becoming Innovation Leader and Solution Provider 2. Strategic Levers to Accelerate – Growth – Innovation – Excellence – Leadership – Sustainability 3. Growth Outlook 12/08/2020 Capital Market Day
Slide 15: Outperforming Markets and Accelerating Growth
Outperforming Markets and Accelerating Growth 15 Definition of Growth Segments Mid to High Market Growth Segments Single Next Level Digit Growth − Innovative products, customers − Advanced solutions and high value products Technologies − Focus on injectables and biotech solutions − M&A − Global expa
Slide 16: Turning Global Trends into Business Opportunities
Turning Global Trends into Business Opportunities 16 Example Injectables Market for injectables with Serve the increasing global demand attractive growth rates The market for injectables is growing Expanding capacity Innovate on high with attractive CAGRs 6-10%: in syringes, vials value solutions: a
Slide 17: Triple Sales with Biologics Customers
Triple Sales with Biologics Customers 17 Example Biologics Gx® Biological Solutions - cross divisional team Innovative product solutions for biotech drugs Best possible packaging configuration Interdisciplinary team of scientists, designers, engineers and product managers Full-service provider for s
Slide 18: Boosted Demand in Injectables
Boosted Demand in Injectables 18 Global Capacity Expansion in Syringes, Vials, Pens & Autoinjectors Injectables made by Gerresheimer – bold formula G targets − Global footprint for syringes − Leverage on vaccine momentum, further grow RTF & Elite vials − Devices: serve key customer projects and expa
Slide 19: Serving our Global Customers
Serving our Global Customers 19 Global Expansion: Increase Footprint and Competence China − Syringes, pipettes, high value vials − Regulated OTC plastics market North America India − High value products and product innovation − Local competence − Increasing service centre South East Asia offering −
Slide 20: Growth With Key Accounts
Growth With Key Accounts 20 Global KAM: Over Proportional Growth With Key Customers Increase revenue potential through Customer centric offering – our Global Key Account Management cross-divisional over all business units − Secure global quotes from customers − Use cross-selling potentials through a
Slide 21: M&A with Further Potential for our Growth Story
M&A with Further Potential for our Growth Story 21 Structured Strategic Evaluation Process for Inorganic Growth − M&A as part of our growth story − Established structured approach for acquisitions Customers − Consider strategic corporations and partnerships Product Innovations Competency Strategic F
Slide 22: Agenda
Agenda 1. Strategy formula G: Becoming Innovation Leader and Solution Provider 2. Strategic Levers to Accelerate – Growth – Innovation – Excellence – Leadership – Sustainability 3. Growth Outlook 12/08/2020 Capital Market Day
Slide 23: Leading in Innovation
Leading in Innovation 23 The Strategic Development Partner of our Customers Opening the minds: establishing a culture of innovation Collaborating Innovation Network One third of sales – internal and external through innovative solutions Innovation process in close cooperation with our customers 12/0
Slide 24: Connect Competence Centers to a Global Network
Connect Competence Centers to a Global Network 24 Group-wide Technology Center Further center Syringes Center Innovation Center planned in Lohr of Excellence Technical Competence Smart Devices / Bünde, Germany Center/Medical Systems Micro Pumps Wackersdorf, Germany Olten, Switzerland New 2019/2020 T
Slide 25: Growth in Elite Glass is now Materializing
Growth in Elite Glass is now Materializing 25 Growth Through Innovative Products Example: Gx® Elite Glass − Reducing the customers’ total cost of ownership − High resistance for breakage and delamination − No need to re-file − Registered for patent Expected sales CAGR 2020-25: ~30% 12/08/2020 Capita
Slide 26: Into the Customer's Value Chain
Into the Customer’s Value Chain 26 High Value Products with RTF Example: Gx® RTF Vials − Increasing demand for ready-to-fill products – moving up the value chain − Offering of pre-washed and sterilized vials as enhancement of product portfolio − Transferring established knowhow and capabilities from
Slide 27: Enlarge Product Portfolio of High Value Solutions
Enlarge Product Portfolio of High Value Solutions 27 Growth Through Innovation and High Value Products Innovative drug delivery Innovative solutions & process/ service capabilities Meaningful Sales Contribution by 2025e Gx Biologic CAGR 2020-25e: Solutions >75% CAGR 2020-25e: >60% Volume Products St
Slide 28: Agenda
Agenda 1. Strategy formula G: Becoming Innovation Leader and Solution Provider 2. Strategic Levers to Accelerate – Growth – Innovation – Excellence – Leadership – Sustainability 3. Growth Outlook 12/08/2020 Capital Market Day
Slide 29: Excellence in Everything we do
Excellence in Everything we do 29 Key Priorities While Striving for Excellence Customers Priority on excellent customer touchpoints Products & Processes Excellent quality and state of the art production Excellence Gerresheimer family on a mission Investors Treat investors like partners Sustainabilit
Slide 30: Quality – Driver of Growth & Profitability
Quality – Driver of Growth & Profitability 30 Excellence in Production Cross-divisional Excellence Council established Target CNQ (%) Clear targets and timeline Driven by improvements in process 6.7% 6.8% capability, especially digitization 6.0% 5.8% Target CNQ <4% − Best-in-class inspection 3.9% ca
Slide 31: Agenda
Agenda 1. Strategy formula G: Becoming Innovation Leader and Solution Provider 2. Strategic Levers to Accelerate – Growth – Innovation – Excellence – Leadership – Sustainability 3. Growth Outlook 12/08/2020 Capital Market Day
Slide 32: Passion for Growth
Passion for Growth 32 Inspire the Whole Organization for Growth Mindset GROWTH MINDSET Challenges help me to grow FIXED Failure is an opportunity to grow Our Values MINDSET Feedback is constructive Teamwork I like to try new things Responsibility Integrety We live our values Bold Innovation Excellen
Slide 33: Agenda
Agenda 1. Strategy formula G: Becoming Innovation Leader and Solution Provider 2. Strategic Levers to Accelerate – Growth – Innovation – Excellence – Leadership – Sustainability 3. Growth Outlook 12/08/2020 Capital Market Day
Slide 34: Rethink the Future: Sustainability as Growth Lever
Rethink the Future: Sustainability as Growth Lever 34 Holistic Approach with Bold Targets Setting new Standards 3 Examples Already strong today: Gx eco-design 50% CO2-savings principles: by 2030e 100% by GxPure GxCircular 2023 GxCare Health & Safety: Ambitious Goals Lost time accident frequency rati
Slide 35: Agenda
Agenda 1. Strategy formula G: Becoming Innovation Leader and Solution Provider 2. Strategic Levers to Accelerate – Growth – Innovation – Excellence – Leadership – Sustainability 3. Growth Outlook 12/08/2020 Capital Market Day
Slide 36: Profitable Growth Accelerating
Profitable Growth Accelerating 36 Revenue Guidance for Core Business in FY 2021 and Beyond …to high single CAGR from mid single… CAGR + 2% 2022 2019 2015 The Transformation is Ongoing
Slide 37: innovating for a better life
innovating for a better life